Please refer to ClinicalTrials.gov : NCT04241068.

JRCT ID: jRCT2080225185

Registered date:01/05/2020

Basic Information

• Recruitment status: completed
• Health condition(s) or Problem(s) studied: Alzheimer's disease
• Date of first enrollment: 17/06/2020
• Target sample size: 2400
• Countries of recruitment: Japan,Asia except Japan,North America,Europe,Oceania
• Study type: Interventional

Intervention(s)

investigational material(s)
Generic name etc :
INN of investigational material : -
Therapeutic category code : 19- Other agents affecting nervous system and sensory organs
Dosage and Administration for Investigational material :

control material(s)
Generic name etc :
INN of investigational material : -
Therapeutic category code :
Dosage and Administration for Investigational material :

Outcome(s)

• Primary Outcome: safety
• Secondary Outcome: -

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Please refer to ClinicalTrials.gov : NCT04241068.
• Exclude criteria: Please refer to ClinicalTrials.gov : NCT04241068.

Related Information

• Primary Sponsor: Biogen Japan Ltd.
• Secondary ID(s): NCT04241068,JapicCTI-205281